ATX-401 (Aurobac Therapeutics)

N/A

Report date: 2024/08/20 11:37:16

Base Information

Drug NameATX-401 (Aurobac Therapeutics)
Drug Alias NameCF-370GN-370ATX-401
ClassificationBiologics > Bacteriophages
Mechanisms of ActionPeptidoglycan modulatorsCell wall inhibitors
TargetsPeptidoglycan
Therapy Area/IndicationsHospital-acquired pneumoniaPneumonia, Ventilator-Associated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaN/A
Originator CompaniesContrafectAurobac Therapeutics SAS
China Registration ClassN/A

Develop Information

Active CompaniesContrafect
Inactive CompaniesN/A
Active IndicationsHospital-acquired pneumoniaPneumonia, Ventilator-Associated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A